Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Hepatology

• Publication date

  1991-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.1840140603PMID 1959884
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term follow-up of chronic post-transfusion non-A, non-B hepatitis: clinical and histological outcome.

  2008cited by this paper
• Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

  1990cited by this paper
• Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa

  1989cited by this paper
• An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

  1989cited by this paper
• Hepatitis C virus antibodies among risk groups in Spain.

  1989cited by this paper
• Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

  1989cited by this paper
• Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

  1989cited by this paper
• Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

  1989cited by this paper
• Posttransfusion hepatitis in Toronto, Canada.

  1988cited by this paper
• Blood-transmitted and clotting-factor-transmitted non-A, non-B hepatitis. Clinical differences and evolution.

  1988cited by this paper
• Chronic Non-A, Non-B Hepatitis: A Long-Term Follow-up Study in 49 Patients

  1987cited by this paper
• A multicenter, prospective study of posttransfusion hepatitis in milan

  1987cited by this paper
• Non-A, non-B posttransfusion hepatitis--a decade later.

  1985cited by this paper
• Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis.

  1984cited by this paper
• Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis.

  1982cited by this paper
• Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

  1981cited by this paper
• The long-term course of non-A, non-B post-transfusion hepatitis.

  1980cited by this paper
• The chronic sequelae of non-A, non-B hepatitis.

  1979cited by this paper
• Transfusion‐associated hepatitis not due to viral hepatitis type A or B †

  1975cited by this paper
• IMPAIRED NEUTROPHIL PHAGOCYTOSIS

  1974cited by this paper
• Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus.

  1974cited by this paper
• A PLAN FOR TANGANYIKA.

  1964cited by this paper

• The Seroprevalence of hepatitis C infection in multiple hemodialysis patients at tertiary care hospital

  2024influential citation
• Geographical variation in hepatitis C-related severe liver disease and patient risk factors: a multicentre cross-sectional study

  2023cites this paper
• Sub-genotypes of hepatitis C virus in the Middle East and North Africa: Patterns of distribution and temporal changes.

  2023cites this paper
• Twenty-year follow-up of an outbreak of hepatitis C in a small rural town of Argentina: The O´Brien Project.

  2021cites this paper
• Hepatitis C Virus

  2020cites this paper
• Clinical Epidemiology of Hepatitis C Virus

  2018cites this paper
• The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions

  2018cites this paper
• Determinants of Infection Outcome in HCV-Genotype 4

  2017cites this paper
• The Financialization of a Cure: A Political Economy of Biomedical Innovation, Pricing, and Public Health

  2017cites this paper
• Within host RNA virus persistence: mechanisms and consequences.

  2017cites this paper
• Peromyscus as a model system for human hepatitis C: An opportunity to advance our understanding of a complex host parasite system.

  2017cites this paper
• Association of oncogenic bacteria with colorectal cancer in South China

  2016cites this paper
• Hepatitis C Virus, Insulin Resistance, and Steatosis

  2016cites this paper
• Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection

  2016cites this paper
• Natural history of chronic hepatitis C

  2016cites this paper
• From THE DEPARTMENT OF MEDICINE, SOLNA Karolinska Institutet, Stockholm, Sweden CHRONIC HEPATITIS MORBIDITY AND MORTALITY IN PATIENTS AND THEIR CHILDREN

  2016cites this paper
• Neutralizing antibodies in patients with chronic hepatitis C and correlation to liver cirrhosis and estimated duration of infection

  2016cites this paper
• Serum metabolome profiles characterized by patients with hepatocellular carcinoma associated with hepatitis B and C.

  2016cites this paper
• 156 – Hepatitis C

  2015cites this paper
• Chapter 10 – Natural History of Hepatitis C

  2015cites this paper
• Prevalence of Cirrhosis in Hepatitis C Patients in the Chronic Hepatitis Cohort Study (CHeCS): A Retrospective and Prospective Observational Study

  2015cites this paper
• Liver fibrosis progression in hepatitis C virus infection after seroconversion.

  2015cites this paper
• Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo

  2015cites this paper
• A Review of the Natural History of Chronic Hepatitis C Infection

  2014cites this paper
• Fibrosis progression in interferon treatment-naive Chinese plasma donors with chronic hepatitis C for 20 years: a cohort study.

  2014cites this paper
• Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseases.

  2014cites this paper
• Pathological characteristics of patients who develop hepatocellular carcinoma with negative results of both serous hepatitis B surface antigen and hepatitis C virus antibody

  2014cites this paper
• Deep Sequencing Insights in Therapeutic shRNA Processing and siRNA Target Cleavage Precision

  2014cites this paper
• On the assessment and impact of liver fibrosis in patients with chronic hepatitis C

  2013cites this paper
• Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: a metabolomics analysis.

  2013cites this paper
• Epidemiology and Prevention of Viral Hepatitis B and C

  2013cites this paper
• Global control of hepatitis C: where challenge meets opportunity

  2013cites this paper
• Virus Infection across Diverse Outcomes of Human Hepatitis C Antigen-Driven Patterns of TCR Bias Are Shared

  2012cites this paper
• Clinical Features of Hepatitis C Virus Carriers With Persistently Normal Alanine Aminotransferase Levels

  2012cites this paper
• Modulation of innate immune responses by hepatitis C virus

  2012cites this paper
• The Potential Role of Cytokines in the Treatment of Viral Infections

  2012cites this paper
• SASLT Practice Guidelines: Management of Hepatitis C Virus Infection

  2012cites this paper
• Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks

  2012cites this paper
• Prevalence of Anti HCV Infection in Patients with Beta-Thalassemia in Isfahan-Iran

  2012cites this paper
•  Natural history of hepatitis C virus infection in a cohort of asymptomatic post-transfused subjects.

  2012cites this paper
• Autologous bone marrow cell infusions suppress tumor initiation in hepatocarcinogenic mice with liver cirrhosis

  2012cites this paper
• Psychiatric and Substance Use Disorders in Individuals with Hepatitis C

  2012cites this paper
• Risk factors for higher anti-HCV positivity in a border city in southern Turkey with unique population characteristics.

  2012cites this paper
• Racial Differences in Fibrosis Progression After HCV-Related Liver Transplantation

  2012cites this paper
• Historia natural de la infección por virus C de la hepatitis

  2012cites this paper
• Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis

  2012cites this paper
• Barriers to accessing hepatitis C for individuals who have experience with injection drug use and are accessing methadone maintenance treatment

  2012cites this paper
• Major Therapeutic Uses of Interferons

  2012cites this paper
• Look-back screening for the identification of transfusion-induced hepatitis C virus infection in Sweden

  2011cites this paper
• Overview of HIV-related disorders

  2011cites this paper
• Diagnostic Accuracy of Serological Markers in Viral Hepatitis and Non Alcoholic Fatty Liver Disease. A Comparative Study in Tertiary Care Hospital of Western Nepal

  2011cites this paper
• Characteristics and prognosis of patients with hepatocellular carcinoma after the year 2000 in Japan

  2011cites this paper
• The Impact of Antiviral Therapy and the Influence of Metabolic Cofactors on the Outcome of Chronic HCV Infection

  2011cites this paper
• Importance of Patient, Provider, and Facility Predictors of Hepatitis C Virus Treatment in Veterans: A National Study

  2011cites this paper
• Antigen-Driven Patterns of TCR Bias Are Shared across Diverse Outcomes of Human Hepatitis C Virus Infection

  2011cites this paper
• Total and cause‐specific mortality rates in a prospective study of community‐acquired hepatitis C virus infection in northern Norway

  2011cites this paper
• Amino Acid Substitutions in the Hepatitis C Virus Core Region Are Associated With Postoperative Recurrence and Survival of Patients With HCV Genotype 1b-Associated Hepatocellular Carcinoma

  2011cites this paper
• Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.

  2010cites this paper
• CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

  2010cites this paper
• An updated follow‐up of chronic hepatitis C after three decades of observation in pediatric patients cured of malignancy

  2010cites this paper
• Cost effectiveness and quality of life considerations in the treatment of hepatitis C infection

  2010cites this paper
• Patients’ Preferences for Treatment of Hepatitis C

  2010cites this paper
• Characteristic expression pattern of oxidative stress in livers with cryptogenic hepatocellular carcinoma.

  2010cites this paper
• Hepatitis C infected hemodialysis and renal transplant patients with elevated α-glutathione S-transferase have increased risk for liver damage

  2010cites this paper
• Lipid Metabolism and HCV Infection

  2010cites this paper
• Hepatitis C Virus Infection Shared across Diverse Outcomes of Human Antigen-Driven Patterns of TCR Bias Are

  2010cites this paper
• Race and Hepatitis C Management within the Veterans Administration

  2010cites this paper
• Clinical outcomes in a prospective study of community-acquired hepatitis C virus infection in Northern Norway

  2010cites this paper
• Possible correlations among viremia, genotypes and liver histology in HCV(+) hemodialysis patients HCV(+) hemodiyaliz hastalarinda viremi, genotip ve karaciğer histolojisi arasindaki

  2010cites this paper
• CT and MRI of hepatocellular carcinoma: an update

  2010cites this paper
• Possible correlations among viremia , genotypes and liver histology in HCV ( + ) hemodialysis patients HCV ( + ) hemodiyaliz hastalar ı nda

  2010cites this paper
• The plasma level of cathelicidin#LL37 in p atients with chronic hepatitis C virus

  2010cites this paper
• Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India

  2009cites this paper
• Cirrhosis and lesion characterization at MR imaging.

  2009cites this paper
• Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection

  2009cites this paper
• Cirrhosis and Lesion Characterization at

  2009cites this paper
• Epidemiology, Risk Factors, and Natural History of Chronic Hepatitis C

  2009cites this paper
• The etiological agent of most cases of post-transfusion hepatitis and a variable proportion of sporadic non-A, non-B hepatitis was discovered in 1989, by recombinant cDNA immunoscreening of serum from a chimpanzee chronicaIIy infected with a conta-

  2009cites this paper
• Increasing public awareness about hepatitis C: development and validation of the brief hepatitis C knowledge scale.

  2009cites this paper
• Effect of interferon α‐2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis

  2009cites this paper
• Lipid droplets and hepatitis C virus infection.

  2009cites this paper
• Clinical and histological impact of previous hepatitis B virus infection in patients with chronic hepatitis C

  2009cites this paper
• The history of the “natural history” of hepatitis C (1968–2009)

  2009cites this paper
• Biopsia hepática:utilidad de métodos cualicuantitativos en diagnóstico y pronóstico de la hepatitis crónica viral

  2009cites this paper
• Seroprevalence of anti HCV antibodies among blood donors in Kathmandu valley, Nepal.

  2009cites this paper
• Outcomes of a patient‐to‐patient outbreak of genotype 3a hepatitis C

  2009cites this paper
• Suppressive effect of oral administration of branched‐chain amino acid granules on oxidative stress and inflammation in HCV‐positive patients with liver cirrhosis

  2008cites this paper
• The hepatitis-associated bile duct lesion.

  2008cites this paper
• Virological characterization and liver histology in HCV positive subjects with normal and elevated ALT levels.

  2008cites this paper
• Differential Expression of the CXCR3 Ligands in Chronic Hepatitis C Virus (HCV) Infection and Their Modulation by HCV In Vitro

  2008cites this paper
• Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.

  2008cites this paper
• Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course.

  2008cites this paper
• Histological outcome of chronic hepatitis C treated with a 12-month course of lymphoblastoid alfa interferon.

  2008cites this paper
• The natural course of HCV infection and the need for treatment.

  2008cites this paper
• Prevalence of hepatitis C and its risk factors in blood donors at Shiraz transfusion center

  2008cites this paper
• Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden – a low endemic country

  2008cites this paper
• Characteristics and prognosis of patients in Japan with viral marker‐negative hepatocellular carcinoma

  2008cites this paper
• A molecular chaperone glucose‐regulated protein 94 blocks apoptosis induced by virus infection

  2008cites this paper
• Histological evolution of chronic hepatitis C. Factors related to progression.

  2008cites this paper
• Investigation of Putative Multisubtype Hepatitis C Virus Infections In Vivo by Heteroduplex Mobility Analysis of Core/Envelope Subgenomes

  2008cites this paper